论文部分内容阅读
本文采用酶联免疫吸附法对141例肝癌、853例供血者及278例肝炎进行甲、乙、丙、丁四型肝炎标志物检测。结果为供血者抗-HCV阳性率12.7%。各类人群中肝癌抗-HCV阳性率最高,为32.3%。各型肝炎分析表明乙肝最高,混合感染以甲+乙最高(7.2%),乙+丙次之(2.5%)。在肝癌中,抗-HCV(+)组与抗-HCV(-)组的HBV-M阳性率分别为95.4%和89.5%。其结果提示:湖南确有HCV存在,生活密切接触不可忽视,丙肝与肝癌存在一定关系,存在混合感染现象,HCV与HBV无明显互相抑制。
In this paper, 141 cases of liver cancer, 853 cases of blood donors and 278 cases of hepatitis were tested for markers of hepatitis B, C, C and D by enzyme-linked immunosorbent assay. The results for the blood donor anti-HCV positive rate of 12.7%. The highest positive rate of anti-HCV in all kinds of people was 32.3%. Hepatitis B analysis showed that the highest hepatitis B, mixed infection with the highest A + B (7.2%), B + C (2.5%). In hepatocellular carcinoma, the positive rates of HBV-M in anti-HCV (+) and anti-HCV (-) groups were 95.4% and 89.5%, respectively. The results suggest that there is indeed HCV in Hunan, close contact with life can not be ignored, there is a certain relationship between hepatitis C and liver cancer, the phenomenon of mixed infection, HCV and HBV were not significantly inhibited each other.